Lincoln Pharmaceuticals Profit & Loss Annual

BSE: 531633 | NSE: LINCOLN | ISIN: INE405C01035 | Sector: Biotechnology & Drugs

617.45 -0.05 (-0.01%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	580.55	510.31	472.12	424.19
Total Revenue	580.55	510.31	472.12	424.19
Costof Revenue Total	278.34	253.34	228.12	206.49
Gross Profit	302.21	256.97	244.01	217.69
Selling/ General/ Admin Expenses Total	102.90	167.24	148.19	130.15
Depreciation/ Amortization	10.62	9.17	8.09	7.56
Other Operating Expenses Total	99.40	0.02	0.03	0.18
Total Operating Expense	491.26	429.76	384.43	344.38
Operating Income	89.29	80.55	87.70	79.80
Interest Inc( Exp) Net- Non- Op Total	-14.65	205.82	89.04	44.62
Other Net	34.42	-0.39	-0.53	-0.36
Net Income Before Taxes	122.24	100.48	95.94	83.72
Provisionfor Income Taxes	28.94	27.58	26.58	21.47
Net Income After Taxes	93.30	72.90	69.36	62.25
Net Income Before Extra Items	93.30	72.90	69.36	62.22
Net Income	93.30	72.90	69.36	62.22
Income Availableto Com Excl Extra Ord	93.30	72.90	69.36	62.22
Income Availableto Com Incl Extra Ord	93.30	72.90	69.36	62.22
Diluted Net Income	93.30	72.90	69.36	62.22
Diluted Weighted Average Shares	2.00	2.00	2.00	2.00
Diluted EPS Excluding Extra Ord Items	46.58	36.40	34.63	31.11
DPS- Common Stock Primary Issue	1.80	1.50	1.50	1.50
Diluted Normalized EPS	46.58	36.49	34.67	31.18
Gain( Loss)on Saleof Assets	-	-2.56	-1.31	-1.82
Minority Interest	-	-	-	-0.03